论文信息 - Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241–1249 - 字舞流文

Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241–1249

T. Hardy | H. Fu | D. Moller | D. Watson | Ying Ding | R. Kelly | A. Lewin | W. Landschulz | P. Garhyan | M. Deeg | C. Shi | C. Kazda | C. N. Lim